Leslie V Norwalk sold $946K of Neurocrine Biosciences (NBIX)

Executed Dec 15 2025, disclosed Dec 17 2025, 2 days later.

Value, as filed

$946K

6,190 sh across 2 lots

Executed

Dec 15 2025

the trade date, as filed

Disclosed

Dec 17 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

LN Leslie V Norwalk Director profile →

Leslie V Norwalk (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $946K of NBIX (6,190 sh across 2 lots, as filed), executed Dec 15 2025.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Leslie V Norwalk in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $228K
1,250 sh × $182.01
Exec Jul 28
Filed Jul 30 · 5:29 PM ET NBIXSALE Neurocrine Biosciences, Inc. $210K
1,250 sh × $168.06
Exec Jun 4
Filed Jun 8 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $591K
3,810 sh × $155.01
Exec May 12
Filed May 14 · 5:30 PM ET